Benjamin Hohl - 23 Feb 2023 Form 3 Insider Report for Enliven Therapeutics, Inc. (ELVN)

Role: Chief Financial Officer
Signature: /s/ Benjamin Hohl
Issuer symbol: ELVN
Transactions as of: 23 Feb 2023
Net transactions value: $0
Form type: 3
Filing time: 27 Feb 2023, 20:25:30 UTC
Next filing: 06 Apr 2023
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney